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While there is an increasing interest in using electromagnetic fields and nanomaterials 
to boost neuronal differentiation and/or protect neurons from oxidative stress, little is 
known about effects of their cells in vitro. We investigated the effect of external 
magnetic fields (alternating current (AC) and direct current (DC) MF) on the neuronal 
viability, differentiation, and neurite outgrowth of SH-SY5Y neuroblastoma human 
cells in vitro. This study indicated that low frequency and fields with weak strength AC 
MF, and fields with high strength DC MF improved the efficiency of retinoic acid 
mediated neuronal differentiation without any adverse effects on neuronal viability; as 
shown by increased length of neurites in SH-SY5Y neuroblastoma cells. The cell 
viability has not changed after AC MF exposure, and it had no real adverse effect on 
cell confluency after DC MF exposure; in fact, even without retinoic acid, AC and DC 
MF promoted neurite outgrowth in low serum conditions. This study has therefore 
identified a simple and cost-effective method for differentiating SH-SY5Y cells without 
expensive reagents. We also describe a novel DC MF source that is simple to apply and 
very efficient, in fact our results suggest that this DC MF system is better than AC MF 
with regards to the viability and differentiation of SH-SY5Y cells. This research is a 
new way of promoting neurite outgrowth in a commonly used neuronal-like cell line 
model. We also tested two different nanomaterials to assess their ability to protect SH-
SY5Y cells. We first tested the cytotoxic effect of oleic acid – coated and uncoated iron 
oxide (Fe3O4) NPs, and the cytotoxic impact of uncoated Yttrium oxide (Y2O3) NPs on 
the viability of neuroblastoma cells in vitro. The anti-oxidant impact of Yttrium oxide 
NPs was explored by checking whether or not it could reduce the oxidative stress 
induced by H2O2 in vitro on SH-SY5Y cells. This study also indicated that Yttrium 
oxide NPs could work as free radical scavengers to reduce the oxidative stress induced 
by hydrogen peroxide in SH-SY5Y cells in culture, however the protective effects were 
complex and depended on the concentration of nanoparticles and hydrogen peroxide 
used. This research provides a first step in understanding the effects that external 
magnetic fields and nanoparticles have on neuronal-like cells in culture. This 
combination of NPs guided by external magnetic field (AC or DC) should be considered 
in future research to exploit all the features of these nanomaterials and magnetic fields 
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1.1 Electromagnetic fields (EMF) 
Globally, a question has arisen regarding the use of electromagnetic field (EMF) on 
brain development, but since avoiding exposure to extremely low-frequency 
electromagnetic field (ELF-EMF) is impossible because electricity is used everywhere, 
it is known as the extremely low frequency (ELF) spectrum because its frequency 
ranges from about 50/60 Hz. External magnetic fields are divided into three levels 
depending on their frequency, that is < 300 Hz, 300 Hz – 10 MHz, and 10 MHz – 300 
GHz. Since ELF is less than 300 Hz, the range of intermediate frequency (IF) is 
between 300 Hz and 10 MHz, and the range of radiofrequency (RF) is between 10 MHz 
and 300 GHz (Wang and Zhang, 2017). Although it is almost impossible to avoid 
exposure to EMF in modern societies, its effect on neurogenesis and neuronal function 
remains unclear, which means that understanding the impact of EMF on neurons is an 
important task. Moreover, a major challenge within the field of cellular neuroscience is 
generating cells that faithfully recapitulate neuronal functions. 
1.2 Effects of ELF-EMF on cells in vitro 
1.2.1 Neurite Outgrowth and Differentiation of various cell models 
after applying ELF-EMF  
Very little is known about on how ELF-EMF exposure affects the embryonic neural 
stem cells (NSC) cellular division and proliferation, how ELF-EMF influences 
embryonic neurogenesis, or how hippocampal neurogenesis in adult mice be enhanced 
by exposure to ELF-EMF. The impact of ELF-EMF on neural stem cells NSCs has been 
researched by Ma and co-authors who exposed NSCs to ELF-EMF (50 Hz, 1mT) for 4 
hours per day over 1, 2, and 3 days; they found that exposing cells to ELF-EMF 
increased the proliferation and maintenance of NSC (Ma et al., 2016). Moreover, after 
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exposure to ELF-EMF, the expression of proneural genes NeuroD and Ngn1 increased; 
they are important for neuronal differentiation and neurite outgrowth.  The exposure of  
ELF-EMF for NSC has improved coupled intracellular Ca+2 by up-regulating the gene 
expression of TRPC1 (Ma et al., 2016). Eliminating this up-regulation of proneural 
genes and promoting neuronal differentiation and neurite outgrowth induced by ELF-
EMF occurred when the TRPC1 expression was silenced (Ma et al., 2016). This result 
suggests that promoting neuronal differentiation coupled with the neurite outgrowth of 
NSCs via up-regulation, the expression of TRPC1 and proneural genes (NeuroD and 
Ngn1) occurs when they are exposed to ELF-EMF. These outcomes help us to 
understand how exposure to ELF-EMF affects the development of embryonic brains  
(Ma et al., 2016). Another important procedure in brain development is neurite 
outgrowth which includes the projection formation and maturation of neuronal fibre 
connections known as synapses (Ma et al., 2016). Moreover, ELF-EMF (50Hz, 1mT) 
increases the growth and division of cells in various cell models such as human 
neuroblastoma (IMR32) and rat pituitary (GH3) cells (Grassi et al., 2004), HL-60 
leukemia cells, rat-1 fibroblasts and WI-38 diploid fibroblasts (Wolf et al., 2005), and 
also promote the cellular division of NSCs (Cuccurazzu et al., 2010, Sherafat et al., 
2012).  
It has been reported that pulsed EMF can also increase the growth of neurites with 
respect to the direction of EMF in different cell models. For instance,  the average 
length of neurites of PC12 rat pheochromocytoma cells increased by ELF-EMF 
exposure in the direction of EMF (Zhang et al., 2006), while the neurite outgrowth of 
dorsal root ganglia (DRG) also increased in the direction of +EMF (Macias et al., 2000).  
Blackman and co-workers tested the impact of an electric field and an AC magnetic 
field (AC MF) on the neurite outgrowth of PC-12D rat pheochromocytoma cells and 
found that whilst 0.2 - 115 μV/m of the electric field had no effect, 2.2 and 4 mT, 50 Hz 
of AC MF stimulated neurite outgrowth (Blackman et al., 1993b).  
1.2.2 The Differentiation of Human Mesenchymal Stem Cells on 
Graphene-Based Substrates is improved by Applying (ELF-EMF). 
Functioning as a remarkable tool for the growth, differentiation, and fate conversion of 
cells, whereas graphene is a non-cytotoxic biocompatible substance whose properties 
enable it to be manipulated for regenerative medicine and tissue engineering as a 
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scaffold for biological tissues. Graphene has probable applications for nerve 
regeneration owing to the substrate support of neuronal differentiation of stem cells 
(Lee et al., 2015), but its application needs improvement because the mechanism for 
differentiation by graphene substrates is still unclear. The biological efficiency of 
neuronal differentiation in bone marrow-derived human mesenchymal stem cells 
(hMSCs) grown on a graphene-coated substrate was improved synergistically when 
exposed to very low frequency electromagnetic fields (ELF-EMF; 50 Hz, 1mT). Lee 
and co-workers found that the expression for 170 genes changed considerably (fold 
change ≥ 1.4) with or without EMF when used with graphene substrate, compared to 
glass only control.  They divided these genes into 4 groups depending on their function: 
(i) Neurogenesis; (ii) Differentiation; (iii) Extracellular matrix; (iv) cell migration. Each 
group contains several genes. We mentioned one gene from each group that changed 
considerably, for instance, NR4A2 (Nuclear receptor subfamily 4, group A, member 2) 
belongs to neurogenesis , EDNRB (Endothelin receptor type B) considers one of the 
differentiation group, CTSG (cathepsin G) belongs to the extracellular matrix group, 
and USP6 (dual specificity phosphatase 6) is considered as part of the cell migration 
group (Lee et al., 2015). Lee and co-authors demonstrated that changes in global gene 
expression profiles could enhance neurogenesis and result in an up-regulation of cell 
adhesion molecules; this requires an intracellular calcium influx and an activated focal 
adhesion kinase signaling pathway that is stimulated by producing extracellular matrix 
protein. These results could form the basis for a very useful therapeutic strategy in 
regenerative medicine (Lee et al., 2015). 
1.2.3 Short term and long term impact of (ELF-EMF) exposure on 
Alzheimer’s disease (AD) 
EMF technology has undergone intensive development and utilisation in recent times so 
as a consequence, the health effects of EMF have also been the focus of research. 
Owing to their potential influence on the induction of Alzheimer’s disease (AD), very 
low-frequency electromagnetic fields (ELF-EMF) have also been studied with 
increasing interest. To study the interaction between ELF-EMF exposure and memory 
degeneracy in rats, Zhang and co-authors selected 20 healthy male Sprague-Dawley 
(SD) rats and divided them into two random groups with a sample size of 10. The 
animals were then subjected to a sham exposure or exposed to 100 μT /50 Hz ELF-EMF 
and then various tests such as, (i) ELISA assays to assess the Amyloid-beta (Aβ) 
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content in the cortex, hippocampus, and plasma; (ii) the Morris water maze (MWM) to 
assess any alteration in cognition and memory; and (iii) hematoxylin and eosin (H & E) 
staining to assess the morphology of neurons. The results indicated that apart from a 
lack of difference in body weight compared to the control group, other indications 
included: (i) no real alterations in the Aβ; (ii) no malfunction in memory and cognition 
compared to the sham exposure group; and (iii) no histological alteration in neuronal 
morphology in the ELF-EMF exposure group. These results indicated that exposure to 
100 μT/50 Hz ELF-EMF did not influence the cognition and memory of the animals, 
and it did not alter their neuron morphology or expression of Aβ (Zhang et al., 2015). 
To uncover the potential influence and underlying mechanism of ELF-EMF exposure 
on living organisms, more extensive research should to be undertaken. 
Alzheimer’s disease (AD) is part of the spectrum of neurodegenerative illnesses that 
could possibly be induced by low-frequency magnetic field (LF-MF). To determine the 
influence of long term exposure to LF-MF (50 Hz, 1mT) with the onset of the AD and 
amyotrophic lateral sclerosis (ALS) in established mouse models, Liebl and co-authors 
undertook extensive research on APP23 mice and mice expressing mutant Cu/Zn-
superoxide dismutase (SOD1), respectively. APP23 transgenic mice is considered to be 
a mouse model of Alzheimer diseases (Van Dam et al., 2014). The learning disorder of 
the APP23 mice did not worsen after continuous exposure for 16 months, and LF-MF 
continuous exposure for 8 and 10 months had no effect on the propagation of disease 
and survival of SOD1G93A or SOD1G85R mice, respectively. Furthermore, continuous 
exposure to LF-MF on SOD1 mice did not increase their protein aggregation and glial 
activation.  Moreover, the same magnetic field did not change the Aβ and APP gene 
level of APP23 transgenic mice. These results and the biochemical assessment of 
protein aggregation, glial activation, and levels of toxic protein species indicate that the 
cellular phenomena involved in the pathogenesis of AD or ALS was not influenced by 
LF-MF (Liebl et al., 2015). 
1.3 Magnetic nanoparticles  
Magnetic nanoparticles (MNPs) can be manipulated with assistance from an external 
magnetic field; without a magnetic field MNPs seem to be characterised by para-
magnetism, whereas within a magnetic field they seem to be characterised by super-
para-magnetism. Although NPs become magnetised after exposure to an external 
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magnetic field (EMF), they do not exhibit remanence (permanent magnetisation once 
the magnetic field is turned off), superparamagnetic iron oxide NPs (SPIONs) are given 
priority over other MNPs (Chomoucka et al., 2010). When the surfaces of SPIONs are 
modified appropriately, they exhibit, (i) stability against aggregation at physiological 
pH within a large range of concentration and ionic strength, (ii) reactive areas that are 
appropriate for further binding of biological ligands with drugs, and (iii) a reduction in 
capture by the immune system (Shkilnyy et al., 2010). Therefore, this surfactant is very 
important in reducing the cytotoxicity of NPs.  
Iron oxides can exhibit stable magnetic responses because they are not as sensitive to 
oxidation as other metals (Tran and Webster, 2010), and therefore iron oxide MNPs 
have many crystalline polymorphs which are appropriate for biomedical applications, 
particularly c-Fe2O3 (maghemite) and Fe3O4 (magnetite) (Tran and Webster, 2010, 
Arruebo et al., 2007, Tuček et al., 2006). 
Being a multi-disciplinary ramification of science, nanotechnology consists of various 
areas of science and technology such as advanced materials science, agricultural 
sciences, biomedicine, chemistry, environmental sciences, information technology, 
pharmaceutics, and physics, among many others (Chatterjee et al., 2014). Nanoscale 
substances are very important for biomedical applications because their sizes are 
comparable with cells (10 – 100μm), viruses (20 – 450 nm), proteins (5 – 50 nm), and 
genes (2 nm wide by 10 – 100 nm long). Moreover, nanoparticles can access areas of 
the body which are otherwise inaccessible through other materials because they are 
small enough and can travel inside human systems without causing any malfunctions 
(Medeiros et al., 2011). Apart from their size, the surface characteristics of MNPs are 
also because adsorbing a different layer of material onto MNPs can enhance their 
surface properties. 
The following coating substances are typically utilised to enhance the surface properties 
of MNPs (Shubayev et al., 2009): (i) Organic surfactants such as  sodium oleate and 
dodecyl amine; (ii) Organic polymers such as  dextran, chitosan, polyethylene glycol 
(PEG), polysorbate and polyaniline; (iii) Inorganic oxides such as silica and carbon; (iv) 
Inorganic metals such as gold; and (v) Bioactive structures and molecules such as 
peptides, liposomes, and ligands/receptors. 
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Unlike ordinary nanoparticles, coated nanoparticles have many advantages due to their 
superior characteristics, these include:  (i) enhanced conjugation with other bioactive 
molecules; (ii) less toxicity; (iii) enhanced thermal and chemical stability; and (iv) 
increased dispersibility and biocompatibility (Chatterjee et al., 2014). 
Moreover, the surfactant coating of MNPs improves the stability of a suspension of 
MNPs in an aqueous solution, as well as preventing the aggregation of NPs due to their 
magnetic features. Oleic acid is one of the most common surfactants and is considered 
to be a biocompatible material that does not activate the cells of an immune system 
(Velusamy et al., 2016). Moreover, the chemical structure of oleic acid, including the 
carboxylic acid, creates the strongest bond with amorphous MNPs. These functionalised 
MNPs with oleic acid increases the monodispersing percentage, gives great 
biocompatibility, reduces toxicity, enhances  stability, and becomes hydrophobic 
(Velusamy et al., 2016). This is why the features of oleic acid attracted us to use it to 
stabilise the MNPs used in this research. 
Depending on their composition, size, shape, electric charge, magnetic and optical 
characteristics, nanoparticles have varying properties, which means they can be altered 
through the conjugation of reactive functional groups and cargos. The nature of this 
interaction between cells and nanoparticles is therefore determined by these 
characteristics, as is their ability to bind or permeate into other cells and to influence 
other biological reactions. This means the cellular reaction to these nanoparticles is 
determined by the nature of these interactions which can be seen in the form of cellular 
morphology, activity or differentiation (Polak and Shefi, 2015).  
1.3.1 Fe3O4 nanoparticles 
For more than five decades, iron oxide (γ-Fe2O3 or Fe3O4) particles have been 
increasingly utilised for in vitro medical diagnostics (Gilchrist et al., 1957), and during 
the last decade, nano-sized iron oxide particles, especially Fe3O4 (magnetite), have been 
widely utilised due to their unique physical properties, ability to be manipulated at the 
molecular level, and their biocompatibility (Kirschvink et al., 2001, Dunlop, 1973, Li et 
al., 2005). The quantum properties that are manifested due to its size combined with the 
large surface area of magnetite enhanced its magnetic properties enough to enable it to 
exhibit superparamagnetism and quantum tunnelling.  
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Consequently, these properties permit a wide range of biomedical applications such as 
cell labelling, cell isolation, payload delivery, tissue repair, and magnetic resonance 
imaging (MRI) contrast enhancement. Moreover, homogeneous ferrofluids can also be 
formed by dispersing the surface functionalised magnetite nanoparticles into an 
appropriate solvent (Strömberg et al., 2007, Sahoo et al., 2005), and by using an 
external magnetic field gradient system, these ferrofluids can be navigated manually to 
any region of the human (or animal) body to carry out therapeutic procedures (Jordan et 
al., 2001, Hosseini et al., 2011, Probst et al., 2011).  
Ferrofluids are currently being used in clinical applications because their administration 
inside a subject is comparatively non-toxic (Enochs et al., 1999). The use of magnetic 
nanoparticles (MNPs) rather than non-magnetic particles has many advantages, 
including: (i) the visualisation of MNPs using MNI and MRI modalities to ascertain that 
payloads have been correctly delivered to the required areas; (ii) navigation and 
positioning of MNPs to any part of a subject using an external magnetic field gradient 
system which can achieve an accuracy of micrometres, and also eliminates the use of 
cell-specific antigen-antibody reactions; and (iii) increasing the temperature of MNPs 
using high-frequency magnetic fields. This fact can be utilised to remove certain tissues 
(for instance cancer tissues) surgically and can also help in releasing a therapeutic drug. 
The controlled release of a drug at a specific region of the body can also be achieved 
when Fe3O4 is subjected to an external magnetic field. The significance of a controlled 
release of drugs using Fe3O4 in vitro by subjecting it to AC/DC magnetic fields was 
highlighted by Mustapić and co-workers in 2016. In fact, magnetic fields have been 
utilised to control the release of methyl blue to water. Here the researchers used methyl 
blue instead of drugs in these experiments so the release of methyl blue into water after 
EMF exposure proved the drug release. Although the application of only a DC field did 
not result in any release, methyl blue was only released to water when an AC field was 
applied. Following this, both fields were applied simultaneously, this resulted in a faster 
release possibly due to viscous friction. When subjected to a DC field, nanoparticles 
become strictly aligned but when they are subjected to an AC field, they start 
oscillating. Similar to the controlled release of methyl blue, this research shows a 
concept of controlled drug delivery where pharmaceutical molecules are first adsorbed 
onto porous Fe3O4, followed by an appropriate localised magnetic field that releases the 
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drug at a specific target (Mustapić et al., 2016). Because of the advantages of iron oxide 
particles (unique physical properties, biocompatibility, and high potential for numerous 
biomedical applications such as payload delivery, tissue repair, and hyperthermia), it 
was used in this research to investigate the effect of these NPs on cells in culture.  
1.3.2 Size of MNPs 
The factor for determining the approximate half-life of MNPs in the bloodstream is their 
size (Durán et al., 2008, Esmail, 2010). Studies show that very large MNPs (diameter > 
200 nm) are quickly absorbed by the reticuloendothelial system (RES) and are then 
found in the spleen and liver while small MNPs (diameter < 5.5 nm) are quickly 
excreted through the renal system (Durán et al., 2008, Veiseh et al., 2010); therefore, to 
control the targeting of any drug, their size should ideally be between these two 
extremes. 
The size of MNPs also determines the concentration of plasma, the half-life of blood 
circulation, and its toxicity. Particles greater than 200 nm either accumulate in the 
spleen or are absorbed by the body’s phagocytic cells which then reduces the 
concentration of plasma particles, whereas particles with diameters less than 10 nm are 
excreted primarily by the renal system. Owing to their toxicity and accumulation in the 
body, particles smaller than 2 nm should not be utilised for such purposes. Particles in 
the range of 10 – 100 nm are optimal for biomedical applications because they are not 
absorbed by the reticuloendothelial system (RES) and thus have a longer life inside the 
bloodstream; and they can also permeate very small blood capillaries (Gupta and Wells, 
2004). Research suggests that to penetrate the blood-brain barrier (BBB) MNPs must be 
smaller than 20 nm for neural stimulation in vivo so that payloads can be delivered to 
specific regions of the brain as required (Yue et al., 2012). We therefore used 20 nm of 
spherical Fe3O4 in our research in vitro.  
1.3.3 Biomedical applications of MNPs 
The provision of therapeutic payloads to diseased tissues with high efficacy, solubility, 
and stability has been the prime concern of medical applications, as well as optimising 
the biodistribution/bioavailability of therapeutic payloads. The proposition to utilise a 
delivery technique that could target particular diseased tissue/organism and provide a 
toxin for that specific disease/organism was first suggested by Estelrich and co-authors 
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(Estelrich et al., 2015). The term “magic bullet” refers to the method used to deliver 
therapeutic payloads to a particular area or to eliminate an organism exclusively. 
To deliver therapeutic drug payloads to particular areas, numerous nanomaterials with 
differing compositions and biological characteristics have recently been designed (Pison 
et al., 2006, Brannon-Peppas and Blanchette, 2004, Stylios et al., 2005, Yokoyama, 
2005, Schätzlein, 2006), but unlike traditional delivery mechanisms, these 
nanomaterials have advantages such as: (i) the provision of payloads to targeted regions 
of the body; (ii) minimisation of the drug (since the drug is delivered to a particular 
site); and (iii) minimisation of any toxic side-effects (since the drug level is minimised 
at irrelevant sites). Apart from these applications, nanomaterials also have potential 
applications in cell imaging, diagnostics, and protein and nucleic acid (DNA/RNA) 
detection. Of this plethora of nanomaterials, those which are widely utilised include Au 
nanoparticles, iron oxide nanoparticles, magneto-electric nanoparticles, Poly (lactic-co-
glycolic acid) nanoparticles, carbon nanotubes, and mesoporous silica nanoparticles. 
These materials are summarised in Figure 1.1. 
 
 
Figure 1.1: (Guduru, 2013) shows advantages and disadvantages of using magnetic 
nanoparticles for various applications. 
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Figure 1 shows the benefits and drawbacks of utilising MNPs for numerous applications 
that were summarised by Gunduru in 2013. Magnetic nanoparticles (MNPs) seem to be 
the most widely utilised nanoscale substances because they consist of a core/shell 
nanoparticle structure with a magnetic core inside an organic or polymeric coating. In 
the absence of a coating, MNPs exhibit hydrophobic properties, and have large surface-
to-volume ratios and a tendency to agglomerate (Lu et al., 2007). 
1.3.4 Biomedical application of Fe3O4 NPs 
Iron oxide nanoparticles (IONPs) are emerging as the focus of biomedical research 
because they have numerous applications in the field as well as a low toxic profile and 
collectability by magnetic fields.  The metabolic mechanism of IONPs in the body was 
used to determine their potential for use as MRI contrast agents; these studies showed 
that initially, iron oxides were transported to the liver and spleen (Weissleder et al., 
1989), but within a week of being administered excess iron was either excreted or 
utilised by the body (Weissleder et al., 1989) as co-factors such as hemoglobin, etc. 
Moreover, IONPs may also function as enzymatic co-factors. To slow the degradation 
of nerve growth factor (NGF) down, Marcus and colleagues combined iron oxide 
nanoparticles with NGF because after NGF and iron oxide nanoparticles conjugate 
covalently, they also slow the degradation of NGF better than free NGF (Marcus et al., 
2015). Furthermore, conjugated NGF promoted the neurite outgrowth of PC12 cells at 
higher levels than the free NGF available at the same level of concentration (Marcus et 
al., 2015). 
Chen and his team also exhibited their almost non-invasive technique for remote neural 
excitation by activating the heat-sensitive capsaicin receptor TRPV1 using Fe3O4 (Chen 
et al., 2015). 
According to Paviolo and colleagues, nanoparticles play a pivotal role in activating 
several transcription factors that can directly influence the growth and differentiation of 
neuronal tissue (Paviolo et al., 2013). Prior studies regarding iron oxide particles 
support this hypothesis. After analysing gene expression,  Park and colleagues observed 
widespread changes in the uptake of Iron oxide nanoparticles uptake on neuronal 
differentiation (Kim et al., 2011). In fact, several gene changes pertaining to cytoplasm, 
signalling machinery, growth hormone receptors and ion channels were reported, all of 
which are essential for the growth and differentiation of neuronal tissue. Several factors 
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that affect this process of growth are certain metal ions that hinder cell to cell adhesion; 
iron is a good example  (Hong et al., 2003).  
1.3.5 Neuronal Regeneration through Magnetic Nanoparticles. 
Neuronal tissue seldom regenerates and therefore trying to recover nerve damage after 
an injury is very difficult (Fu and Gordon, 1997). Although a great deal of research and 
various procedures have been carried out trying to achieve neuronal regeneration, thus 
far it has been a futile exercise because they are therapeutically in applicable. However, 
medical science has come a long way and new research is being carried out, which 
means the recent discoveries in magnetic nanotechnology are proving to be very 
beneficial at regenerating neuronal tissue (Franze and Guck, 2010, Bray, 1979, Bray, 
1984, Fass and Odde, 2003). One hypothesis that could explain neurite elongation is that 
magnetic nanoparticles can apply a mechanical force that will stretch the plasma 
neuronal membrane. This means that nanoparticles of iron oxide could be beneficial 
because they have the required properties and their previous usage in such experiments 
have been fruitful (Blackman et al., 1993a, Ciofani et al., 2009) . This theory was tested 
by Riggio and co-authors who successfully used Iron oxide nanoparticles, Schwann 
cells cultures, and SH-SY5Y to migrate without causing any cytotoxicity (Riggio et al., 
2012).  
The Mergel lab adopted another approach to induce  neuronal tissue regrowth using 
nanoparticles of Conjugated Iron oxide to increase the efficacy of the Fibroblast growth 
factor (Skaat et al., 2011). The fibroblast growth factor has a half-life of only 3-10 
minutes (Bikfalvi et al., 1997) so it can help to repair and regrow injured or damaged 
tissues in the body (Yun et al., 2010); in fact after  incubating conjugated nanoparticles 
with cells from nasal olfactory mucosa, there was marked increase in cellular growth. 
Clearly a better understanding of the relationship between nanoparticles and neuronal 
regeneration and regrowth could pave the way for a therapeutic remedy for those 
suffering from neural tissue injuries. Several parameters considered during this therapy 
are worth mentioning; it is imperative to determine a balanced dose in order to draw a 
line between a therapeutic dose and a toxic dose, other than this morphology, activity, 
or drug delivery.  
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1.3.6 Cytotoxicity of iron oxide nanoparticles (IONPs) on Cell Lines  
The basic pathophysiology by which metal ions influence gene expression is not very 
clear, possibly due to the production of reactive oxygen species (ROS) (Oravecz et al., 
2002). The coating of NPs helps to protect nanoparticle from agglomeration and 
minimise the rate of surface oxidation, and particle size can be controlled with a stable 
coating material during the synthesis process. Nanoparticles without a coating are 
unstable, more exposed to the immune system, have increased chemical reactivity, and 
are easily oxidised (Santhosh and Ulrih, 2013). Organic ligands, a natural polymer, 
synthetic polymers, inorganic molecules, and biological molecules are some of the 
coating materials used (Carlson et al., 2008). A study to assess the cellular uptake of 
iron oxide NPs (IONPs) and different cell lines was carried out, and revealed that the 
efficiency of nanoparticle uptake depended on the surface coating, the cell line did not 
influence uptake at all (Karlsson et al., 2008). This study established a positive 
association between the surface coating and the biocompatibility of nanoparticles and 
also showed that it could decrease the IONP toxicity. An in vitro study was carried out 
on A3 human T lymphocytes, and revealed that the cytotoxicity of IONPs coated with 
ligands with terminal carboxylic acid groups was higher than those coated with ligands 
with terminal amine groups (Buzea et al., 2007). Chen et al. used mouse fibroblast cells 
(L929 cells), murine macrophage cells (RAW264.7 cells), and a Chinese hamster 
ovarian cells (CHO-K1 cells) to show that coated Fe3O4 NPs cause less DNA damage 
than uncoated Fe3O4 NPs (Chen et al., 2012). 
The cellular uptake of IONPs depends on the coating characteristics and the size of the 
nanoparticles (Safi et al., 2010), however, remember that the doses of IONPs with 
which cells were treated are presented here, but they do not always represent the true 
amount of internalised iron (Safi et al., 2010). This may cause problems because the 
amount of internalised IONPs is made with an NP dose, the coating composition and 
thickness, and the media composition (Safi et al., 2011), all of which may influence the 
levels of mutagenicity. Therefore, the dose of nanoparticles contributes to but is not 
solely responsible for the cellular internalisation of IONPs (Galimard et al., 2012). 
Moreover, in various types of cells, iron is considered to be essential for their survival, 
e.g., the chick myotubes degenerated  when a proper iron supplementation was not 
provided to the basal culture medium (Ozawa and Hagiwara, 1982). The important 
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factors used in these studies are explained and presented below by Polack and co-
workers. These factors are classified on the basis of their activity, type of nanoparticle, 
coating, use, type of activity, and toxicity (Polak and Shefi, 2015). Iron oxide is also 
included in Table 1.1 as a factor of nanoparticles. 
Table 1.1: (Polak and Shefi, 2015)The most important factors in the studies, classified on the 
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1.4 SH-SY5Y cells 
Many researchers use neuronal-like cancer cell lines such as human SH-SY5Y or mouse 
Neuro2a neuroblastoma cells to provide relatively easy access to a vast number of cells 
for analysis (Shipley et al., 2016). These cycling cells are commonly differentiated into 
more neuronal-like cells for functional analyses. To do this, cells can be serum starved 
and /or treated with an agent such as retinoic acid (RA) or cyclic adenosine-3',5'-
monophosphate (cAMP) to promote neuronal differentiation (Shipley et al., 2016). 
1.5 Aims 
  
1. To compare the effect of AC and DC Magnetic fields on the cell viability of SH-
SY5Y neuroblastoma human cells in vitro (Chapter 3). 
2. To compare the influence AC and DC MF on the neurite outgrowth of SH-SY5Y 
cells with and without retinoic acid in vitro (Chapter 3). 
3. To measure the cytotoxic impact of iron oxide nanoparticles (IONPs) Fe3O4 NPs on 














SH-SY5Y cell culture 
SH-SY5Y neuroblastoma cells (94030304, Sigma) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) / F12 pH 7.4 (Life Technologies, 12500096), 
supplemented with 10 % foetal bovine serum (FBS, Bovogen), and 1 % 
penicillin/streptomycin (PS, Life Technologies, 15140-122). The cells were kept in 
culture for up to 22 passages and maintained at 37 °C in a 5 % CO2 atmosphere; they 
routinely underwent mycoplasma testing (MycoAlert, Lonza) and were confirmed by 
STR profiling. 
The impact of AC and DC MF on Cell viability 
The SH-SY5Y cells were plated into 96 – well microplates at 12000 cells per well. The 
cells were cultured in (DMEM) / F12 pH 7.4 supplemented with 10 % foetal bovine 
serum and 1 % PS.  On the first day the cells were plated a concentration of 12000 / well 
cells were seeded in the plates.  The cells were then treated with AC or DC MF every 
day for 2 or 3 days, starting 24 hours after plating, depending on the experimental 
conditions. The cells were cultured for 48 hours without any further treatment with 
EMF. The fluorescent intensity of the reagent composed from AlamarBlue and the cells 
was read on the plate reader (BMG - POLARstar Omega) 2 hours after adding the 
viability reagent to the cells.  
The cytotoxicity test of homemade and commercial MNPs  
The cytotoxicity of iron oxide NPs was assessed by the AlamarBlue assay 
(ThermoFisher, DAL1100). SH-SY5Y neuroblastoma human cells were subcultured in 
96 – well / flat – bottomed (FB) microplates (Interpath Services, 655180X) using 
DMEM / F12, 1 % PS, and 10 % FBS. On the first day, a concentration of 12000 / well 
cells were seeded in the plates and on the second day the cells were treated with 
different concentrations of MNPs, depending on the type of MNPs. These homemade 
MNPs was dispersed in distilled water (D.W) because it was uncoated NPs (bare), 
whereas the commercial MNPs were dispersed in ethanol absolute because the NPs 
were coated with oleic acid (Fatty acid and hydrophobic). There were two ranges of a 
serial dilution of NPs; the first being (5, 10, 15, 20, 25, 30, 37.5, 45, and 50 µg / ml), 
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and the second being (10, 20, 30, 40, 50, 60, 75, 90, and 100 µg / ml). AlamarBlue 
reagent (1:100 PBS) was added 48 hours later. The fluorescent intensity of the reagent 
composed from the AlamarBlue reagent and SH-SY5Y cells was read on the plate 
reader (BMG - POLARstar Omega) 2 hours after adding the cell viability reagent to the 
cells.  
The effect of AC and DC MF on Neuronal differentiation 
The SH-SY5Y cells were plated into 96 – well microplates at 5000 cells per well and 
then cultured for 7 days. To induce differentiation in the cells, the culture media was 
replaced with differentiation media (DMEM/F12, 1% PS, 1% FBS, 10 µM all-trans 
retinoic acid (RA, R2625, Sigma)) after 24 hours, followed by 100 % media changes 
every 48 hours. Dimethyl sulfoxide (DMSO) was used as a vehicle control for the RA, 
and the vehicle control medium was also changed every 48 hours. SH-SY5Y cells were 
treated with different intensities of AC or DC MF (either with or without RA) for 2 or 3 
days, starting 24 hours after plating, and the cells were cultured without any further 
exposure to EMF until Day 7  Figure 2.1 Cell images were collected every day using an 
IncuCyte Zoom live imaging system.  
 





Magnetic Exposure System  
The magnetic exposure system holder was designed to hold an AC coil and commercial 
N52 grade rare earth (NdFeB) permanent magnets (DC magnetic) in close proximity in 
order to obtain a uniform and controlled field gradient by varying the distance between 
the AC coil and the permanent magnets. The holder was made from acrylic (Perspex) 
material to ensure safety while applying an AC current to the coil. The AC magnetic 
field exposure system has one circular copper coil (air core) with 400 turns and 10 
layers; it was designed at Coast Electrical Industries Pty Limited to fit inside the coil 
holder which is connected by a 300 mm long rod. The coil is 15 mm long × 160 mm in 
diameter, and has an internal diameter of 60mm, as shown in Figure 2.2. The wire used 
in the coil is 1.25 mm in diameter. The coil is connected to the function generator (GFG 
200/2100) that applies the frequencies and power amplifier (Sinocera Piezotronics, INC, 
model: YE5873H) to deliver an alternating current of up to 3.6 A. Two sizes (Ø6.4×5 
and are Ø15.6×3 mm) of N52NdFeB cylinder magnets were purchased from Chongqing 
Seatrend Technology and Development. Co., Ltd., and the 4 larger and 5 smaller 
magnets were placed in parallel on the base of the magnetic system holder, as shown in 
Figure 2.2. The 96 – well microplate placed as a flat surface over the MF source 
direction (AC and DC sources) to ensure maintaining uniform and high magnetic flux 
intensity. The perpendicular MF direction on the exposed cell surface area of microplate 
prevents loses in the MF flux intensity. The strength of MF intensity and frequency for 





Figure 2.2: Magnetic exposure system holder designed using the Solid Material software. It 
consists of a base which containing two sizes of neodymium cylinder magnets, base, rod, a plate 
holder, and a coil holder. 
TEM images of the homemade and commercial MNPs 
Transmission electron microscopy (TEM) images of the homemade Fe3O4 NPs were 
taken by Dean Cardillo, but the TEM images of the commercial Fe3O4 NPs were taken 
by the supplier company.  
Dynamic Light scattering test (DLS test) on homemade 
MNPs 
Serial dilutions of homemade MNPs (uncoated NPs) were prepared to start from (10 µg 
/ ml to 100 µg / ml) in distilled water (D.W.), and then 100 µl of 10 µg/ml concentration 
were added to one well of 96 – well / flat – bottomed (FB) microplates (Interpath 
Services, 655180X) and placed inside a particle analyser to check the particle size 
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distribution. The particle size distribution of MNPs was checked using a particle 
analyser (Malvern – Zetasizer APS2000, IHMRI).  
Dynamic Light scattering test (DLS test) on commercial 
MNPs 
The same process was carried out on the commercial MNPs (coated NPs), but the 
coated MNPs were dispersed in (Ethanol Absolute, Ajax FineChem, Catalogue NO: 
214, CAS NO: 64175) instead of D.W. because the surfactant is oleic acid 
(hydrophobic).   
Statistics 
The data for AC, DC, Fe3O4 NPs are given as the mean ± standard error of the mean 
(SEM) from at least 3 independent replicates. Statistical differences were identified after 
confirming the normal distribution by one or two repeated measures using ANOVA 
with a Tukey post hoc comparison, as appropriate, in Graph Pad Prism software. 
However, the combined AC / DC data are given as the mean ± standard error of the 
mean from 3 technical replicates that were analysed by t-test in Graph Pad Prism 
software. The cell images were analysed by the IncuCyte software to acquire data on 
neurite length, cell confluency, and neurite branch points. Data from the dynamic light 




Chapter 3  
Results: The effect of EMF on SH-SY5Y 
viability and neurite outgrowth 
 
The effect of EMF on SH-SY5Y cells is currently unclear, so to investigate the effect of 
EMF on neurite outgrowth it was important to establish whether EMF affected cell 
viability. 
To investigate the impact of DC MF on cell viability, different intensities of DC MF 
(10, 25, 50, 75, 100, 125, and 150mT) were optimised for different treatment times 1, 2, 
and 4 hours / day over 1, 2, and 3 days. The SH-SY5Y neuroblastoma cells were treated 
separately with various intensities (1, 5, and 10 mT) and different frequencies (50 and 
100 Hz) of AC magnetic fields. These conditions were also optimised for different 
treatment periods of 1, 2, and 4 hours / day for 1, 2, and 3 days.  The findings indicated 
that only 10 mT with 50 and 100 Hz of AC MF reduced cell viability. There was also no 
difference between the impact of 50 and 100 Hz while the intensity of the magnetic 
field was constant (1 mT) after treating the cells for 4 hours / day for 3 days.  
A number of optimisation experiments with varying AC and DC MF intensities and 
durations were also tested outside the incubator, but since the results varied, these 
conditions were not pursued (data not shown). All the other experiments were carried 
out inside the incubator and are shown in the following sections.    
No significant effect of DC MF on cell viability 
A 100 mT for 4 hours / day for 3 days proved to be the best conditions for treating cells 
without any negative impact on cell viability. A paired t-test revealed there was no real 
difference between cells treated with DC MF compared to the control (t = 0.1471, p = 
0.8924, Figure 3.1 A).  
No significant impact of AC EMF on cell viability 
AC MF conditions were optimised and 100 Hz AC MF with a constant magnetic field 
strength of 1 mT for 4 h/day for 2 days was the best condition for treating cells without 




Figure 3.1: (A) Cell viability was assessed by AlamarBlue assay to investigate the impact of 
100 mT of DC MF. There was no real difference between the treated samples and the control. 
(B) cell viability test was also carried out to investigate the impact of treating the cells with 1 
mT, 100 Hz of AC MF for 4 hours/day over 3 days. There was no significant difference 
between the treated cells compared to the control. 
The influence of combined DC / AC MF on cell viability 
When the DC and AC MF conditions were optimised separately, one strength field of 
each type was used to carry out a combined DC and AC test on cell viability. It was 
assumed that a combined DC / AC might increase cell viability so two experiments 
were carried out to test the impact of long and short periods of treatment for a combined 
DC / AC MF.  In the first experiment, two plates were prepared for SH-SY5Y cells, and 
then each plate was treated separately for 2 or 4 hours with 1 mT, 100 Hz of AC, in 
combination with 100 mT of DC EMF. The cell morphology changed to a spherical 
shape (rounding up of cells normally associated with cell death) in both plates by the 
end of the treatment time. An AlamarBlue assay after 48 hours to check cell viability 
suggested many cell deaths (overall one – way ANOVA findings F(2, 6) = 607.4, p < 
0.0001, Figure 3.2 A). A post hoc analysis revealed a large decrease in cell viability 
compared to the control (p < 0.0001 for both 2 and 4 hours of treatment, Figure 3.2 A). 
In the second experiment, three plates were prepared for SH-SY5Y cells, each plate was 
treated separately for 30, 60, or 90 minutes under the same conditions of combined DC / 
AC MF. Treatment for 60 and 90 minutes changed the cell morphology as much as long 
periods of treatment. An AlamarBlue assay after 48 hours showed alterations in cell 
viability (overall one – way ANOVA findings F(3, 8) = 142.8, p < 0.0001, Figure 3.2 B). 
A post hoc analysis identified a large decrease in cell viability (p < 0.0001 for 60 and 90 
minutes of treatment, Figure 3.2 B). However, 30 minutes of treatment had no adverse 
effect on cell viability, but since there was a dramatic reduction in cell viability caused 
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by a combination of AC and DC treatment, we continued the experiments using only 
AC or DC treatments alone.  
 
Figure 3.2: (A) Cell viability was assessed by AlamarBlue assay to investigate the impact of 
both 100 mT of DC, and 1 mT, 100 Hz of AC for 2 and 4 hours on cell viability. There were 
large differences for both long treatment times. (B) Cell viability was also tested by AlamarBlue 
assay to explore the effect of 100 mT of DC, and 1 mT, 100 Hz of AC for 30, 60 and 90 minutes 
on the cell viability. There was no real change after treating the cells for 30 minutes but there 
were large differences after treating the cell for 60 and 90 minutes under the same conditions of 
MF.  
The effects of AC and DC MF on neurite outgrowth 
SH-SY5Y cells were treated with external magnetic fields under either an AC or DC 
magnetic field to investigate the impact of EMF on neurite outgrowth and cell viability. 
A range of magnetic field strengths were tested to identify the optimal conditions for 
treatment. The conditions outlined below represent the best outcomes; this involved 
using a magnetic field strength of 1 mT, 100 Hz of AC MF or 100 mT of DC MF. The 
samples were treated with 1 mT, 100 Hz of AC MF or 100 mT of DC MF for 4 
hours/day over 2 or 3 days. Images of the cells were collected every day until Day 7. 
The effects of external magnetic fields on cells were assessed, included measuring the 







(1) Treating cells with DC or AC MF for 4 h / day for 2 days 
(i) In the presence of RA: To assess the impact of MF on neurite outgrowth, the cells 
were grown in a medium containing 1% FBS supplemented with RA every other day 
for the 7 Day differentiation, and DMSO was used as a vehicle control in these tests. 
There was no significant impact (overall two-way repeated measures ANOVA F (3, 8) = 
0.4948, p = 0.6959) of either DC or AC MF on cell confluency (Figure 3.3 A). the 
neurite increased in length for both types of MF (overall two-way repeated measures 
ANOVA F (3, 8) = 37.68, p < 0.0001). A post hoc analysis revealed a significant increase 
in neurite length, starting from Day 3 until Day 7 for both AC and DC (p < 0.01 for 
Days 3 to 7, Figure 3.3 B). This means that the impact became significant 24 hours 
after the last treatment. The effect of DC MF + RA on Days 3 – 7 led to a larger 
increase in neurite length compared to RA alone, than the AC MF + RA treatment. 
Nevertheless, the effects of AC MF became equal to or higher than the DC MF impact 
by Days 6-7 (Figure 3.3 B). Moreover, the neurite branch points were increased 
significantly by DC MF + RA and AC MF + RA, compared to RA alone, also starting 
from Day 3 until Day 7 (overall two-way repeated measure ANOVA findings, F (3, 8) = 
21.54, p = 0.0001); a post hoc analysis identified a significant increase for Days 3 – 7 
for both AC MF + RA and DC MF + RA compared to RA alone (p < 0.05 for Days 3 – 
7, Figure 3.3 C). The impact of AC MF on Day 3 to 7 had a lower and more varied 
effect on the neurite outgrowth than the DC MF treatment (Figure 3.3 C). 
(ii) In the absence of RA: To assess the effect of MF in the absence of RA, RA was 
omitted from the cell culture medium and the effects of MF on neurite length and 
branch points were assessed as shown previously. Both DC and AC MF had similar 
effects on neurite outgrowth, as shown in Figure 4, even without RA. In these 
experiments MF was applied to cells cultured in a medium containing 1% FBS, so 1% 
FBS without MF application was utilised as the control. Cells cultured under 10% FBS 
were used as a further control and showed reduced/absent neurite extensions (Figure 
3.3 D – F). As shown previously, both types of MF had no effect on cell confluency 
(overall two-way repeated measure ANOVA findings F (3, 8) = 11.34, p = 0.0030, Figure 
3.3 D). However, the neurite length increased significantly with both types of MF 
compared to control (overall two-way repeated measure ANOVA findings F (3, 8) = 
16.92, p = 0.0008). A post hoc analysis identified a significant increase starting from 
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Day 5 until Day 7 for DC (p < 0.05 for days 5 – 7, Figure 3.3 E), and Day 6 to 7 for AC 
(p < 0.05 for days 6 to 7, Figure 3.3 E). This means that the effect became significant 4 
days after the last treatment day for DC and 5 days for AC. Therefore, DC MF was 
better at increasing the neurite length than AC MF (had a larger effect earlier in the 
differentiation process). However, the effects of AC MF were similar to DC MF by Day 
7 (Figure 3.3 E). Furthermore, the neurite branch points increased significantly starting 
from Day 6 to 7 for DC while the impact of AC MF led to greatly enhanced neurite 
branch points on Day 7 (overall two-way repeated measure ANOVA findings, F (3, 8) = 
6.347, p = 0.0165); a post hoc analysis identified a significant increase starting on Day 6 
for DC MF (p < 0.05 for Days 6 – 7, Figure 3.3 F), and on Day 7 for AC MF (p < 0.01 
for Day 7). The influence of AC MF on the neurite branch points occurred 24 hours 





Figure 3.3: Impact of AC and DC MF treatment for 4 hours/day over 2 days on the neurite 
outgrowth of SH-SY5Y cells in the presence and absence of RA. The cells were treated 
separately with 1 mT, 100 Hz of AC MF, and 100 mT of DC MF, for 4 h/day for 2 days. (A – 
C) shows the effects of AC and DC MF on the neurite outgrowth with RA. There was no real 
change in cell confluency (A). However, the treatment did increase the neurite length and 
neurite branch points starting from Day 3 until Day 7 (B – C). (D – F) illustrates the influence 
of the same conditions of MF on SH-SY5Y cells without RA in 1% FBS containing cell culture 
medium. There was no real change in cell confluency following either MF treatment (D). DC 
MF or AC MF treatment increased the neurite length and neurite branch points, but starting 
from Day 5 for neurite length and Day 6 for neurite branch points (E-F), the differences 
compared to 1% FBS without RA on the same day are shown *p < 0.05, **p < 0.01, ***p < 0.001, 
and ****p < 0.0001. 
In order to identify how treating the cells 4 hours / day for 2 days affected neurite 
outgrowth, see (Figure 3.4), the impact of the conditions mentioned above on the 
neuronal differentiation of the cells with and without RA is shown in Images (A – H). 
These Images are related to the presence of RA, while DMSO was utilised as a vehicle 
control for RA. DMSO had no effect on the neurite length and neurite branch points, as 
shown in image (A), but RA did reduce cell confluency and promoted neurite length 
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and neurite branch points compared to A, as shown in image B.  Moreover, the effect of 
DC MF on cell confluency and neurite outgrowth was more effective than AC MF 
compared to A, as shown in image C, however the second group of images are without 
RA and 1% FBS was used as a control, see (E - H). The effect of 1% FBS and without 
DMSO on cell confluency and neurite outgrowth is shown in image (E); here it reduced 
cell confluency but had no positive impact on neuronal differentiation, see (E). 
However, 1% FBS had a strong effect when the DMSO was attending, as indicated in 
image A compared to E. When DMSO and RA, which reduced cell proliferation and 
induced cell differentiation are absent, and the concentration of FBS is 10%, cell 
confluency increased significantly, as shown in image F compared to images A, B, and 
E. However, there was no effect with 10% FBS on the neuronal differentiation, see (F). 
The impact of DC MF on cell confluency and neurite outgrowth is shown in Image (G). 
When there is no differentiation reagent, cell confluency will decrease more by treating 
the cell with DC MF than treating the cells with 1% FBS only, as indicated in image G 
compared to E. Even though treating the cells with DC and RA reduced cell confluency 
more than treating the cells with DC and 1%FBS only, the DC MF could induce cell 
differentiation by reducing cell proliferation, and it could replace a differentiation 
reagent, as shown in image G compared to C. Moreover, the neurite outgrowth was also 
significantly enhanced by treating the cells with DC MF, even when RA is absent, as 
shown in image G compared to C. The impact of AC MF on cell confluency and neurite 
outgrowth is shown in image (H), where AC MF also reduced cell proliferation. 
Further, cell confluency with AC MF decreased more than when treating the cells with 
1%FBS or (DC + 1% FBS), as shown in image H compared to E and G. This result 
shows that AC MF could also induce neuronal differentiation by reducing cell 
proliferation. When treating cells with (AC+1%FBS), cell confluency was still higher 
than when treating them with (AC+RA), as shown in image H compared to D. 
However, it does not mean that AC MF did not induce neuronal differentiation or that it 
did not work as an alternative method for differentiation reagent, as indicated in image 
H compared to D. AC MF also significantly increased the neurite outgrowth, but it had 
less impact on neurite outgrowth than DC MF because neurite outgrowth was more 
effective with DC MF treatment than with AC MF treatment. All the images mentioned 
above were collected on Day 7 of the experiments. To sum up, DC and AC MF could 
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induce neuronal differentiation by reducing cell confluency and significantly increasing 
neurite outgrowth. 
 
Figure 3.4: IncuCyte images demonstrating the effects of treating SH-SY5Y cells for 4 
hours/day over 2 days with AC and DC MF on neurite outgrowth in the presence and absence of 
RA. Images (A – D) are related to the presence of RA. Images (E – H) are associated with the 
absence of RA. All images were collected on Day 7. Yellow refers to the cell body and purple 
refers to the neurites. Scale bar is 300 µm. 
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(2) Treating the cells with DC or AC MF for 4 h / day for 3 days 
(i) In the presence of RA: As stated previously, the cells were cultured in a medium 
containing 1% FBS supplemented with RA and with or without DC or AC MF 
treatment, and DMSO was used as vehicle control. There was no significant impact 
(overall two-way repeated measure ANOVA findings F (3, 8) = 3.275, p = 0.0798) of 
either DC or AC MF on the cell confluency (Figure 3.5 A). Neurite length had 
increased significantly for both types of MF (overall two-way repeated measure 
ANOVA findings F (3, 8) = 203.6, p < 0.0001), and a post hoc analysis had identified a 
large increase starting from Day 3 until Day 7 for both AC and DC (p < 0.01 for Days 3 
to 7, Figure 3.5 B) for the 2 day treatments; this means that the impact became 
significant on the last treatment day. The neurite branch points had also increased, 
starting from Days 3 – 7 in both types of MF (overall two-way repeated measures 
ANOVA findings, F (3, 8) = 37.45, p < 0.0001), and a post hoc analysis identified a large 
increase starting from Days 3 – 7 for both AC and DC MF (p < 0.05 for Days 3 – 7, 
Figure 3.5 C).  
(ii) In the absence of RA: RA was absent in other experiments however, and that 
showed how the same conditions of EMF affected neurite outgrowth, as shown in 
Figure 3.5, where 1% FBS was utilised as the control. Both types of MF had no real 
impact (overall two-way repeated measures ANOVA findings F (3, 8) = 3.237, p = 
0.0818) of on cell confluency, as shown in (Figure 3.5 D), but the neurite length for 
both types of MF (overall two-way repeated measure ANOVA findings F (3, 8) = 30.58, 
p < 0.0001) had increased. A post hoc analysis identified a large increase on Day 7 for 
DC (p < 0.0001 for day 7, Figure 3.5 E), and AC (p < 0.05 for day 7, Figure 3.5 E), 
which means that the effect became important 4 days after the last treatment day for 
both types of MF. Furthermore, the neurite branch points had increased starting on Day 
6 for DC MF only, while the impact of AC MF did not enhance the neurite branch 
points on Day 6 or 7 (overall two-way repeated measure ANOVA findings, F (3, 8) = 
6.497, p = 0.0155); a post hoc analysis discovered a large promote starting from Days 6 
– 7 for DC MF (p < 0.05 for Days 6 - 7, Figure 3.5 F). Together this suggests that the 
effects of DC MF on neuritogenesis were more effective than AC MF. Moreover, whilst 
3 days of treatment rather than 2 days had no further benefit with RA present, treating 
the cells for 2 days rather than 3 days without RA promoted neurite outgrowth because 
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the ratio of cell confluency for 2 days treatment was higher than for 3 days treatment, as 
shown in Figure 3.3 D compared to Figure 3.5 D, and the neurite length increased 
starting on Day 5 for 2 days treatment and started on Day 7 for 3 days treatment, as 
shown in Figure 3.3 E compared to Figure 3.5 E. Finally, after 2 days of treatment the 
neurite branch points increased starting on Day 6 for DC MF and on Day 7 for AC MF. 
After 3 days of treatment the neurite branch points had increased starting on Day 6 for 
DC MF only, but the impact of AC MF did not enhance the neurite branch points on 
Day 6 or 7 very much, as shown in Figure 3.3 F compared to Figure 3.5 F. 
 
Figure 3.5: The impact of AC and DC MF treatment for 4 hours / day for 3 days on the neurite 
outgrowth of SH-SY5Y cells in the presence and absence of RA. The cells were treated 
separately with 1 mT, 100 Hz of AC MF, and 100 mT of DC MF for 4 hours /day for 3 days. (A 
– C) illustrates the impact of MF on neurite outgrowth in the presence of RA.  There was no real 
change in cell confluency (A). The treatment increased the neurite length and neurite branch 
points starting from Day 3 until Day 7 (B – C). (D – F) shows the influence of MF on neurite 
outgrowth in the absence of RA, but there was no real change in cell confluency (D). The 
treatment increased the neurite length and neurite branch points, starting from Day 7 for neurite 
length and Day 6 for neurite branch points (E – F). These real differences compared to 1% FBS 
without RA on the same day are shown *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.   
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The impact of treating the cells for 4 hours / day for 3 days on the neurite outgrowth 
with and without RA, with 1% FBS used as the control, is shown in the exemplary 
images in (Figure 3.6). The effect of the first conditions of MF with RA is shown in 
images (A – D), but the impact of the aforementioned conditions of MF on the neuronal 
differentiation when RA is absent is shown in images (E – F). When RA was present, 
there was no difference between the morphology of cells treated with the first and 
second sets of conditions, as shown in Figure 3.4 (C and D) compared to Figure 3.6 (C 
and D), but when RA was absent, there was a huge difference between the morphology 
of the cell treated with the first and second sets of conditions, particularly the AC MF, 
as shown in Figure 3.4 H compared to Figure 3.6 H. The morphology of cells treated 
for 4 hours / day for 3 days of AC MF without RA became spherical and aggregated and 




Figure 3.6: IncuCyte images illustrating the impact of treating SH-SY5Y cells for 4 hours/day 
over 3 days with DC and AC MF on neurite outgrowth in the presence and absence of RA. 
Images (A – D) are related to the presence of RA. Images (E – H) are associated with the 
absence of RA. All images were collected on Day 7. Yellow refers to the cell body and purple 
refers to the neurites. The scale bar is 300 µm. 
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Comparison of the effect of DC and AC MF on neurite 
outgrowth 
  
The fold change in neurite length following DC and AC MF treatment with and without 
RA is shown in Table 3.1. The fold change in neurite branch points following DC and 
AC MF treatment with and without RA is shown in Table 3.2. 
Table 3.1: Comparison between the fold change in neurite length of MF compared to control in 
the 4 hours / day for 2 days and 4 hours / day for 3 days conditions when RA is present and 




4 hours / day for 2 days  4 hours / day for 3 days  
Presence of RA Absence of RA Presence of RA Absence of RA 
DC MF AC MF DC MF AC MF DC MF AC MF DC MF AC MF 
Day 1 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 
Day 2 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 
Day 3 2.9 ± 0.1*** 3.3 ± 0.3**** n.s. n.s. 4.1 ± 0.4**** 3.9 ± 0.7**** n.s. n.s. 
Day 4 2.5 ± 0.1**** n.s. n.s. n.s. 2.5 ± 0.1**** 1.4 ± 0.1* n.s. n.s. 
Day 5 3.1 ± 0.1**** 2.2 ± 0.2** 4.7 ± 0.9* n.s. 3.6 ± 0.4**** 2.5 ± 0.3**** n.s. n.s. 
Day 6 2.2 ± 0.1**** 2.8 ± 0.7**** 2  ± 0.1*** 1.7 ± 0.2* 2.2 ± 0.2**** 3.2 ± 0.4**** n.s. n.s. 
Day 7 2.3 ± 0.01**** 2.3 ± 0.3**** 2.9 ± 0.3**** 2.1 ± 0.5**** 2.6 ± 0.2**** 2.3 ± 0.2**** 3.3 ± 0.2**** 2.1 ± 0.5* 
 
Table 3.2: Comparison between the fold change in neurite branch points of MF compared to 
control in the 4 hours / day for 2 days and 4 hours / day for 3 days conditions when RA is 




4 hours / day for 2 days  4 hours / day for 3 days 
Presence of RA Absence of RA Presence of RA Absence of RA 
DC MF AC MF DC MF AC MF DC MF AC MF DC MF AC MF 
Day 1 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 
Day 2 n.s. n.s. n.s. n.s. n.s. n.s. n.s. n.s. 
Day 3 3.1 ± 0.2** 3.7 ± 0.5**** n.s. n.s. 4.3 ± 0.4**** 4.1 ± 0.9**** n.s. n.s. 
Day 4 2.8 ± 0.1**** n.s. n.s. n.s. 2.9 ± 0.1**** 1.6 ± 0.1* n.s. n.s. 
Day 5 3 ± 0.3**** 2.1 ± 0.3* n.s. n.s. 3.8 ± 0.5**** 2.6 ± 0.3**** n.s. n.s. 
Day 6 2.2 ± 0.06** 2.8 ± 0.7**** 2.1 ± 0.1* n.s. 2 ± 0.2*** 3.1 ± 0.3**** 2 ± 0.04* n.s. 








Chapter 4  
Results: The effect of MNPs on the cell 
viability of SH-SY5Y 
The impact of homemade and commercial MNPs (Fe3O4 
NPs) on cell viability 
Both types of MF increased the neurite outgrowth of SH-SY5Y cells, but AC MF only 
enhanced cell viability. MNPs can respond to external magnetic fields so Fe3O4 NPs 
were tested. MNPs could be guided by EMF in further experiments to exploit the 
features of EMF and MNPs together, but we needed to test whether MNPs affect cell 
viability. Since the difference between the impact of coated and uncoated MNPs on the 
cell viability of SH-SY5Y cells is currently unknown, we first investigated their impact 
on cell viability.  
TEM images of homemade and commercial MNPs 
Homemade MNPs were tested (Fe3O4 NPs) first, after being synthesised by team 
member Dean Cardillo in the Innovation campus of University of Wollongong. The NPs 
were between 10 – 15 nm and were uncoated (bare NPs), but unfortunately this led to 
their aggregation so these clusters and aggregated NPs increased to around 50 – 80 nm 




Figure 4.1: TEM image of homemade MNPs. The scale bar of A and B image is 20 nm. 
However, the scale bar of C image is 50 nm. 
Because of the issue with aggregation in vitro we also tested commercial MNPs (Fe3O4 
NPs) purchased from Blacktrace Holdings Ltd, UK. These NPs were 20.16 ± 0.8 nm. 
The NPs were in powder form and coated with oleic acid to reduce aggregation and 




Figure 4.2: (A – C) TEM images of the commercial Fe3O4 NPs. (D) particles size distribution 
of Fe3O4 NPs which indicate that the high ratio of Fe3O4 NPs is around 20 nm. NPs were 
dispersed in a toluene (organic solvent) to take the TEM images. The scale bar of (A) image is 
110 nm, (B) image is 60 nm, and (C) image is 20 nm.  
DLS test of homemade and commercial MNPs 
Three records of both types of MNPs were collected from the particle analyser 
instrument, as shown in Figures 4.3 and 4.4. Because the homemade MNPs were 
uncoated they aggregated to different size clusters, as shown in Figure 4.3. There were 
various percentages of NPs between 250 – 1000 nm, some of which were less than 10 % 
as record 1 shows, however the ratio of NPs around 500 nm was 65 %, as record 2 
shows. Also, the percentage of NPs which were less than 500 nm was around 45 %, as 




Figure 4.3: DLS test of homemade MNPs which indicate the particle size distribution in 
distilled water. 
However, because the commercial MNPs were coated with oleic acid, which is 
hydrophobic, they were dispersed in ethanol absolute (organic solvent) which destroyed 
the surfactant of MNPs that caused the NPs to aggregate, as shown in Figure 4.4. The 
percentage of NPs between 1000 – 1250 nm was 30 %, as record 1 shows, whereas the 
percentage of NPs of 500 nm was more than 80 %, as record 2 indicates. There were 
two different percentages of NPs sizes, the first percentage was 15 % related to sizes 
between 500 – 1000 nm while the second percentage was around 20 % associated to 
sizes between 5 – 6 µm, as record 3 shows. 
 
















































Cytotoxicity assessment of both types of MNPs 
Homemade MNPs 
The serial dilution of MNPs was assessed using AlamarBlue assay. There was no real 
effect on cell viability for the different concentrations of NPs, apart from 60 and 75 
µg/ml of it (overall repeated measures one – way ANOVA findings F (9, 20) = 5.908, p = 
0.0005). A post hoc analysis revealed a significant decrease in cell viability for the 60 
and 75 µg / ml (p < 0.05 for 60 µg / ml, and p < 0.01 for 75 µg / ml, Figure 4.5).  
 
Figure 4.5: The cytotoxicity of serial dilution of homemade MNPs. AlamarBlue assay was 
conducted to assess the cytotoxicity of theses concentrations. There were only two real 
differences compared to the control (C). The p – value of 60 µg/ml vs. (C) is *p < 0.05 while it 
was **p < 0.01 for 75 µg/ml vs. C.  
Commercial MNPs 
An AlamarBlue assay was also carried out to test the cytotoxicity of commercial MNPs, 
but since the DLS test indicate that large clusters of NPs had formed because the 
surfactant for some NPs had been destroyed by the ethanol absolute, we tested the 
impact that a narrow range of NPs concentrations (5, 10, 15, 20, 25, 30, 37.5, 45, and 50 
µg / ml) made on cell viability (overall repeated measures one – way ANOVA findings 
F (9, 50) = 0.882, p = 0.5475, Figure 4.6); theses concentrations had no real impact on  
cell viability. It was therefore suggested that the cytotoxicity of a wide range of MNPs 
(10, 20, 30, 40, 50, 60, 75, 90, and 100 µg / ml) be tested; there were no real changes in 
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the wide range of NPs (overall repeated measures one – way ANOVA findings F (9, 20) = 
0.1332, p = 0.9981, Figure 4.7).  
 
Figure 4.6: The cytotoxicity of narrow range of commercial MNPs concentrations. An 
AlamarBlue assay was carried out to determine the impact that these concentrations made on 
SH-SY5Y cell viability; there was no real difference compared to the control (C).   
 
Figure 4.7: The cytotoxicity of wide range of commercial MNPs concentrations. An 
AlamarBlue assay was carried out to determine how these concentrations would impact on SH-
SY5Y cell viability; there was no real difference compared to the control (C).  
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Chapter 5  
Discussion 
5.1 AC and DC MF 
Previous studies have reported that cell proliferation in various cell models has 
increased because of ELF-EMF exposure (Grassi et al., 2004, Wolf et al., 2005). The 
results of our cell viability that follow AC MF treatment do not agree with the results 
reported recently by Ma and co-workers (Ma et al., 2016). Even though eNSC and SH-
SY5Y neuronal cells were treated with the same strength field of AC MF (1 mT), Ma et 
al used lower frequencies (50 instead of our 100 Hz), but the cell proliferation of both 
types of neuronal cells is changed. Also, in this study the cell proliferation findings 
following DC MF treatment do not show any significant change.   
Both sets of conditions (4 hours / day over 2 or 3 days) increased neuronal 
differentiation starting on Day 3, and with RA, and the neurite outgrowth (neurite length 
and neurite branch points) increased from Day 3 to 7 for both types of MF, but there 
was no increase in neurite length or the number neurite branch points after the treatment 
expanded from 2 to 3 days with and without RA.  However, increasing the time 
exposure without RA reduced this effect on neurite length and the number of neurite 
branch points, especially for AC MF. This result occurred because the 3 day treatment 
by AC MF led to a slight decrease in confluence, as shown in Figure 3.6 H compared to 
Figure 3.4 H. The impact of MF on reactive oxygen species (ROS) has been described 
(Wang and Zhang, 2017), but the influence of MF depends parameters that contain the 
exposure time, frequency, the intensity of MF, and increasing or decreasing the ROS 
level within the cells (Wang and Zhang, 2017). In this study, when the exposure time 
increased from 2 to 3 days, the ROS level might increase within the cell culture and 
reduce the cell activity.  
Previous research has also reported that treating eNSCs, PC12 cell, and dorsal root 
ganglia (DRG) with a very low requency electromagnetic field (ELF-EMF) could 
increase the neurite outgrowth (Zhang et al., 2006, Macias et al., 2000, Ma et al., 2016), 
but an 1800 MHz radiofrequency electromagnetic field (RF-EMF) reduced the neurite 
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outgrowth of NSCs (Chen et al., 2014). Therefore, this study focused on the impact that 
low frequency EMF exposure may have on the neurite outgrowth of SH-SY5Y cells. 
The findings of this research into the neuronal differentiation of SH-SH5Y cells are 
compatible with the results of neuronal cells previously reported by (Ma et al., 2016, 
Zhang et al., 2006, Macias et al., 2000). Our results are compatible with theirs due to 
the large neurite outgrowth of neuronal cells after exposure to AC MF.  
The mechanism for inducing neurite outgrowth by exposure to ELF-EMF has already 
been reported and discussed (Ma et al., 2016). In a growing brain, Ngn1 and NeuroD 
which belong to pro-neuronal basic helix-loop-helix (bHLH) factors that organise the 
neurite outgrowth of NSCs (Imayoshi and Kageyama, 2014, Britz et al., 2006). Ma and 
co-authors found that the expression for proneural genes NeuroD and Ngn1, which are 
crucial for neuronal differentiation and neurite outgrowth, had increased after the 
exposure of NSCs to 1 mT, 50 Hz of AC MF for 4 hours / day over 3 days, but exposure 
to 1800 MHz (RF-EMF) resulted in down-regulation for pro-neuronal genes NeuroD 
and Ngn1 thereby decreasing the neurite outgrowth of NSCs (Chen et al., 2014). 
Previous studies also reported that members of the Mammalian TRPC family 
contributed to the neuronal differentiation and proliferation of NSCs, and various 
members of it participated in regulating neurite outgrowth (Li et al., 2012, Greka et al., 
2003). TRPC1 enhanced the neurite outgrowth in PC12 cells whereas TRPC5 decreased 
it (Heo et al., 2012). Furthermore, EMF exposure for NSC largely improved the 
intracellular Ca+2 coupled by significantly up-regulating the gene expression of TRPC1 
(Ma et al., 2016). Ma and co-workers also found that the Tuj1+ neurons which 
differentiated from NSCs expressed TRPC1, showed that TRPC1 may help to regulate 
neurite outgrowth (Ma et al., 2016).   
Many instruments were used to apply an AC electromagnetic field in the previous 
studies, however, instruments such as a coil, power amplifier, and function generator are 
more expensive than permanent magnets, and they can become damaged when 
connected to electricity. The permanent magnets used in this study are safer than 
electromagnetic devices because they are not connected to the power source. Therefore, 
the DC MF source (permanent magnets) used in this study is simpler, safer, and more 
cost-effective (since consumable-free) than the AC electromagnetic equipment that was 
previously used. Permanent magnets can also produce stronger magnetic fields than the 
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AC electromagnetic equipment because it can reach almost 300 mT or higher depending 
on the size of the magnet. Previous studies also stated that the neuronal differentiation 
of different cell models was enhanced after treating the cells with a DC electric field 
(Kobelt et al., 2014, Ariza et al., 2010, Zhao et al., 2015). This study also described a 
novel method and DC MF source that is simple to apply and very efficient. The impact 
of DC MF on cell viability matched the culture confluence, with both results showing 
that DC MF did not enhance the cell proliferation of SH-SY5Y neuroblastoma cells. 
Moreover, the results of this study associated with the influence of DC MF on neurite 
differentiation might be compatible with the latest findings reported by Zhao et al. 
(Zhao et al., 2015). They indicated that a DC electric field can enhance directional 
migration and stem cell differentiation, suggestively facilitated by calcium influx 
through DC electric field exposure.   
Regarding the mechanism of inducing neurite outgrowth by DC MF, we hypothesize 
that DC MF would work as AC MF and it might induce the gene expression of pro-
neuronal genes such as NeuroD and Ngn1, which are crucial for neuronal differentiation 
and neuronal extension. DC MF may also increase the gene expression of the Tuj1+ 
neuron that expressed the TRPC1 which facilitated the Ca+2 influxes. 
RA induces neuronal differentiation and limits the proliferation of neuronal-like cell 
lines and neural progenitors (Janesick et al., 2015), however, long periods of 
differentiation (beyond 8-10 days) with RA are problematic due to the accumulation of 
proliferating cells (Encinas et al., 2000). RA efficiency is selective for neuronal cells 
because it is not as good at differentiating between induced pluripotent stem cells 
(iPSCs) and embryonic stem cells (ESCs). The efficiency of neural differentiation in 
iPSCs was much lower than ESCs (Hou et al., 2014), so  the neuronal differentiation 
experiments carried out in this study were tested for up to 7 days. We also found that 
DC MF can promote the neurite extension of neuroblastoma cells in the absence of RA 
so DC MF would be the best option to replace RA to induce neuronal differentiation 
beyond 8 – 10 days. We have thus identified a simple, cost-effective method of 
differentiating SH-SY5Y cells without using expensive reagents such as RA.  
5.2 Fe3O4 NPs  
AC and DC MF increased the neurite outgrowth of SH-SY5Y cells, whereas AC MF 
only enhanced cell viability because MNPs can respond to external magnetic fields 
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(Chomoucka et al., 2010), and the iron might include the metabolism of mammalian 
cells such as DNA replication and electron transport in mitochondria (Laskey et al., 
1988); Fe3O4 NPs was included in this research.   
We found that treating SH-SY5Y cells with 60 and 75 µg / ml of homemade Fe3O4 NPs 
led to a large decrease in their viability; this might belong to the aggregation that 
happened while  preparing the serial dilution in D.W because the MNPs were not coated 
with any type of surfactant to prevent their aggregation and sedimentation in the cell 
culture; it might also belong to the cellular uptake of uncoated NPs because the cellular 
uptake of IONPs depends on the coating characteristics and the size of the nanoparticles 
(Safi et al., 2010). Remember that the doses of IONPs with which cells were treated are 
presented, but these values do not always represent the true amount of internalised iron 
(Safi et al., 2010). This may cause many problems because the amount of internalised 
IONPs are made with an NP dose, a coating composition, the coating thickness and 
media composition (Safi et al., 2011), all of which may influence the levels of 
mutagenicity. It must therefore be established that the dose of nanoparticles contributes 
to but is not solely responsible for the cellular internalisation of IONPs (Galimard et al., 
2012). 
Furthermore, these findings are not consistent because there was no mono – distribution 
for the aggregated NPs among the serial dilutions of uncoated NPs. A non-mono 
distribution of the clusters will lead to this kind of trend, but there was no significant 
increase or decrease in cell viability after treating the cells with both ranges of 
commercial NPs. Nevertheless, the SEM in both ranges of coated NPs concentrations 
was wide and inconsistent with the various concentrations. A high range of SEM issue 
can be related to the destroyed surfactant of some NPs because the ethanol absolute 
causes some clusters and aggregated NPs. These clusters might not be distributed in an 
inhomogeneous way because the different serial dilutions of NPs caused a wide range of 
SEM. The coated MNPs had a lower cytotoxic impact on the viability of SH-SY5Y 
cells than uncoated NPs. Chen and co-workers used a single cell line to show that 
coated Fe3O4 NPs caused less DNA damage than uncoated Fe3O4 NPs (Chen et al., 
2012). The cytotoxic effects of nanoparticles can be (Soto et al., 2007, Gutwein and 
Webster, 2004), attributed to the formation of reactive oxygen species that cause 
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oxidative stress (Salvi and Holgate, 1999, Shi et al., 2003). However, the mechanism of 
these toxic effects is yet to be established.  
Modern technology and biomedical sciences have taken quite a leap with advancement 
in production and the use of nanoparticles, but like any other entity, nanoparticles have 
their fair share of limitations because some studies suggest nanoparticles may have 
adverse effects on biological cells such as mitochondrial damage, oxidative stress, 
chromosomal and oxidative DNA damage, changes in cell cycle regulation and 
denaturation of proteins (Nel et al., 2006, Carlson et al., 2008, Karlsson et al., 2008). 
The cytotoxic effects of nanoparticles can be (Soto et al., 2007, Gutwein and Webster, 
2004), attributed to the formation of reactive oxygen species that cause oxidative stress 
(Salvi and Holgate, 1999, Shi et al., 2003). The toxicity of nanomaterials when 
interacting with Biosystems are rather difficult to carry out as there is no adequate 
characterisation of the materials used in such biological studies (Nunes et al., 2012, 
Cellot et al., 2010).  
A great deal of research has been carried out over the past twenty years on the adverse 
effects of iron, particularly its potential to induce necrosis in mammalian cells by 
generating a reactive oxygen species through the Fenton reaction (Bacon and Britton, 
1990, Gutteridge, 1986, Kotamraju et al., 2002, Quinlan et al., 2002). The importance of 
iron for the normal metabolism of mammalian cells is undeniable because it is involved 
in DNA replication and electron transport in mitochondria (Laskey et al., 1988). For 
these reasons, iron oxide nanoparticles are the subject matter of this study.  
In summary, coated and uncoated Fe3O4 NPs did not enhance the viability of SH-SY5Y 
cells, but two different concentrations (60 and 75 µg / ml) of uncoated MNPs 
significantly reduced cell viability. Therefore, coated MNPs combined with Y2O3 NPs 
are the best option for future research. 
5.4 Future direction of the research  
Further research should be undertaken to test the expression of the proneural genes, 
NeuroD1 and Ngn1, and the intracellular calcium level to understand the mechanism 
underlying DC MF and AC EMF on the proliferation and differentiation of SH-SY5Y 
neuroblastoma human cells. With regards to how a combined DC / AC MF affects cell 
viability and neurite outgrowth, different conditions for combined DC / AC MF must be 
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optimised. Further research should also be undertaken to examine the cellular up-take of 
Fe3O4 NPs or the internalisation of these NPs by using flow cytometry and confocal 
microscopy methods to determine where the NPs are located because it could help to 
declare whether the cytotoxicity of NPs occurred within the medium or inside the cells. 
Moreover, knowing their locations can help us understand the cytotoxicity and 
mechanism of the toxic effects of MNPs.  
In this study we have found that the AC and DC MF increase the neurite outgrowth of 
SH-SY5Y cells, and AC MF can enhance cell viability, and the coated Fe3O4 NPs did 
not cause any significant change in cell viability compared to the uncoated ones.  
A magnetic field can induce the neuron cells to increase their viability and neurite 
outgrowth, and it might also control the migration and direction of the neurites.   
Fe3O4 NPs guided by EMF can also help to induce the cells chemically and 
mechanically, while the iron of MNPs might be involved in the metabolic process of 
mammalian cells such as DNA replication and electron transport in mitochondria. The 
mechanical tension via the pull for the membrane of neuron cells by the Fe3O4 NPs and 
EMF might increase the elongation of the neurites; in fact, both processes would induce 
the neuron cells chemically and mechanically.  
5.5 Conclusion 
The outcomes of this research have indicated the impact of external magnetic fields (AC 
and DC) and magnetic nanoparticles (Fe3O4 NPs) on SH-SY5Y neuroblastoma cells. 
The viability of SH-SY5Y neuroblastoma cells was not significantly changed following 
AC MF treatment, and there was also no real change following DC MF treatment. SH-
SY5Y cells under external magnetic fields (either AC or DC), with or without RA, 
increased the neurite outgrowth (neurite length and neurite branch points) without 
negatively affecting cell viability or cell confluency. Without RA, both types of 
magnetic fields increased the neurite outgrowth after being treated for 4 hours per day 
for either 2 or 3 days. However, 2 days of treatment for both types of MF was better at 
promoting neurite outgrowth than treatment for 3 days, and DC MF was better at 
promoting neurite length and neurite branch points than AC MF. This study also 
established a positive association between the surface coating and biocompatibility of 
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Appendix (Preliminary Collaborative 
Study on application of Yttria ceramic 
nanoparticles for ROS scavenging) 
Introduction  
1.1 Yttrium oxide nanoparticles (Y2O3 NPs) 
Antioxidant NPs such as Yttrium oxide NPs (Y2O3 NPs) can work as a free radical 
scavenger to reduce oxidative stress (Ghaznavi et al., 2015, Hosseini et al., 2015).  
Treating cells with magnetic nanoparticles (MNPs) might cause them to die, especially 
cells with uncoated MNPs; uncoated MNPs are more cytotoxic than coated MNPs. 
Chen et al. used a single cell line to show that coated Fe3O4 NPs caused less DNA 
damage than uncoated Fe3O4 NPs (Chen et al., 2012).  
It has been previously reported that Y2O3 NPs can protect neuron cells. Schubert and co-
authors found that yttrium oxide NPs are not toxic to cell culture and can protect a 
HT22 hippocampal nerve cell line from oxidative stress induced by exogenous glutamic 
acid (Schubert et al., 2006). Schubert and co-workers observed three different 
explanations for how Y2O3 NPs protects cells from the oxidative stress: (i) it may work 
directly as antioxidant NPs; (ii) it may inhibit the production of Reactive oxygen species 
(ROS) in HT22 by stopping one step of the programmed cell death pathway; (iii) Y2O3 
NPs might directly reduce the production of ROS that quickly excites the ROS defence 
system before completing the cell death program induced by the glutamate (Schubert et 
al., 2006).           
1.2 Oxidative stress 
Oxidative stress is a component of numerous neurodegenerative diseases such as 
Alzheimer’s disease (Querfurth  and LaFerla 2010) that can be caused by intracellular 
and extracellular sources. With intracellular sources, mitochondria are the major source 
of ROS (Wang and Zhang, 2017).  
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Oxidative stress can be caused by mitochondrial dysfunction and is a result of an 
abnormal generation of ROS that could result in neuronal death (Querfurth  and LaFerla 
2010, Huang and Mucke, 2012, Tu et al., 2014, Kamenetz et al., 2003). The oxidative 
phosphorylation process that occurs inside the mitochondria provides cells with 
adenosine triphosphate (ATP) to maintain cellular energy homeostasis. The reactive 
oxygen species (ROS) by-products produced during this procedure can lead to 
mitochondrial dysfunctions (Federico et al., 2012, Yun and Finkel, 2014, Lin and Beal, 
2006, Wang and Zhang, 2017). Peroxisome is another organelle considered to be 
another major source of intracellular ROS; this because xanthine oxidase in the 
membranes of peroxisomes generates hydrogen peroxide and •O2
- (Wang and Zhang, 
2017).  
However, since NADPH oxidases (nicotinamide adenine dinucleotide phosphate-
oxidase) are one of the extracellular sources of ROS, NADPH oxidases are considered 
to be one of the family of membrane bound-enzymes that face the extracellular space to 
produce ROS, especially in some immune system cells such as macrophage and 
neutrophils cells (Wang and Zhang, 2017, Zhu et al., 2016).  
1.3 Detoxification of ROS 
The elimination for ROS can be assisted by antioxidant enzymes which work as a free 
radical scavenger or through non-enzymatic molecules such as vitamins (A, C, and E), 
flavonoids, and glutathione. Most of the many different organisms developed an 
antioxidant protection system to scavenge extreme ROS. The antioxidant defence 
system of these living organisms consists of enzymes such as glutathione peroxidase 
(GSH-Px), glutathione reductase (GSH-R), catalase (CAT), and superoxide dismutase 
(SOD) or non-enzymatic compounds. SOD, which is one of these antioxidant enzymes, 
is crucial to eliminate the toxicity of ROS. The glutathione S-transferase (GST), (GSH-
Px), glutathione (GSH), and glutathione reductase GSH-R create the glutathione system. 
GSH helps to reduce the oxidative stress caused by disulfide bonds of cytoplasmic 
proteins, but oxidative stress can also be reduced by changing the bonds of cytoplasmic 
proteins to cysteines by GSH, during which GSH will be oxidised to glutathione 
disulphide (GSSG) (Wang and Zhang, 2017). 
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1.4 Advanced Multifunctional Materials for site-specific 
free radical scavenging  
Alzheimer is a neurodegenerative disease, it is the most common type of dementia and 
it influences almost 10% of the aged community who are in their sixth or more decade 
of life.  Mitochondrial dysfunction is the result of an abnormal generation of reactive 
oxygen species (ROS) that can result in neuron death (Querfurth  and LaFerla 2010, 
Huang and Mucke, 2012, Tu et al., 2014, Kamenetz et al., 2003).  
The oxidative phosphorylation process which occurs inside mitochondria provides cells 
with adenosine triphosphate (ATP) to keep cellular energy homeostasis. By- products of 
the reactive oxygen species (ROS) processed during this procedure can lead to 
mitochondrial dysfunction (Federico et al., 2012, Yun and Finkel, 2014, Lin and Beal, 
2006).  
Ceria nanoparticles (CeO2) NPs use their catalase-mimetic activities and superoxide 
dismutase mimetic to defend cells against the superoxide and hydrogen peroxide that 
are the two major products of reactive oxygen species (Karakoti et al., 2010, Celardo et 
al., 2011, Karakoti et al., 2009). Kwon and co-workers synthesized small and positively 
charged triphenylphosphonium ceria (TPP-ceria) NPs capable of targeting mitochondria 
in several cell lines. To sum up, in vitro and in vivo TPP-ceria NPs have shown they are 
biocompatible and can scavenge mitochondrial reactive oxygen species (ROS) capable 
of decreasing oxidative stress (Kwon et al., 2016).  
The research of Lee and co-authors aimed to evaluate the antioxidant activities of 
mixture nanorods such as Au @ Pt NPs. They found it can block and prevent any 
radical production could cause oxidative stress in various line cells. In vitro experiments 
have shown that Au@Pt NPs present a cellular defence against oxidative stress that is 
encouraged by hydrogen peroxide (H2O2). They assessed in vitro the antioxidant 
capability of Au@Pt NPs by measuring the cell viability of many different line cells 
such as Chinese hamster lung fibroblasts and human prostate cancer cells under 
oxidative stress encouraged by H2O2. In summary, their experiments showed that 
Au@Pt NPs provides a cellular defence against oxidative stress that is encouraged by 
hydrogen peroxide (Lee et al., 2014).  
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Furthermore, cerium and yttrium oxide nanoparticles were tested in the research carried 
out by Schubert and co-workers; they found that even though these types of 
nanoparticles had a cytotoxic impact on the cells, it has features which directly act as 
antioxidant NPs to reduce the volume of ROS and thereby reduce the possibility of cell 
death. These kinds of NPs can be utilised to limit the oxidative stress caused by ROS in 
a biological system (Schubert et al., 2006).  
Moreover, antioxidant NPs such as Yttrium oxide NPs (Y2O3 NPs) can also work as a 
free radical scavenger to reduce oxidative stress (Ghaznavi et al., 2015, Hosseini et al., 
2015), so Yttrium oxide NPs were used in this study to reduce the extreme ROS level in 
the cell culture induce by H2O2.  
1.5 Aim 
To test the antioxidant impact of Yttrium oxide nanoparticles (Y2O3 NPs) on the 
oxidative stress induced by H2O2 in vitro  
The nanoparticles were synthesised and provided by Mr. Dean Cardillo, member of the 
Nanoceramics for Health Protection (NCHP) group at the Innovation Campus working 
under the supervision of Group Leader Dr. K. Konstantinov. This study is a part of a 
broad collaborative research program of the team dedicated to application of 












2. Experimental works and design  
SH-SY5Y cell culture 
SH-SY5Y neuroblastoma cells (94030304, Sigma) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) / F12 pH 7.4 (Life Technologies, 12500096), 
supplemented with 10 % foetal bovine serum (FBS, Bovogen), and 1 % 
penicillin/streptomycin (PS, Life Technologies, 15140-122). The cells were kept in 
culture for up to 22 passages and maintained at 37 °C in a 5 % CO2 atmosphere; they 
routinely underwent mycoplasma testing (MycoAlert, Lonza) and were confirmed by 
STR profiling. 
The cytotoxicity test of homemade Y2O3 NPs   
The cytotoxicity of Yttrium oxide NPs was assessed by the AlamarBlue assay 
(ThermoFisher, DAL1100). The SH-SY5Y neuroblastoma human cells were 
subcultured in 96 – well / flat – bottomed (FB) microplates (Interpath Services, 
655180X) by using DMEM / F12, 1 % PS, and 10 % FBS. On the first day the cells 
were plated a concentration of 12000 / well cells were seeded in the plates.  The Y2O3 
NPs were dispersed in a phosphate buffer saline (PBS) prepared at IHMRI by technical 
officers (TOs). The ingredients of PBS were Potassium Chloride, Astral Scientific, 
BIOPB0440-500G, Potassium Phosphate, Bio – Strategy, VWRC0781-1KG, Sodium 
Chloride, ThermoFisher, AJA465-5KG, and Sodium Phosphate, Astral Scientific, 
BIOS0404-500G. On the second day the cells began treatment with three different 
concentrations of Yttrium oxide NPs (5, 15, and 25 µg / ml). PBS was used as a control 
(1:1000 medium), and AlamarBlue reagent (1:100 PBS) was added 48 hours later. The 
fluorescent intensity of the composed reagent from AlamarBlue reagent and SH-SY5Y 
cells was read on the plate reader (BMG - POLARstar Omega) 2 hours after adding the 
cell viability reagent to the cells.  
The cytotoxicity test of hydrogen peroxide (H2O2) 
The cytotoxicity of H2O2 (Sigma – Aldrich, H1009) was also tested by the AlamarBlue
 
assay (ThermoFisher, DAL1100). SH-SY5Y neuroblastoma human cells were 
subcultured in 96 – well / flat – bottomed (FB) microplates (Interpath Services, 
655180X) by using DMEM / F12, 1 % PS, and 10 % FBS. On the first day the cells 
were plated, a concentration of 12000 / well cells were seeded and on the second day, 
the cells were treated with three different concentrations of hydrogen peroxide (0.025, 
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0.05, and 0.075 milliMolar). D.W was used as a control (1:1000 medium), and 
AlamarBlue reagent (1:100 PBS) was added 48 hours later. The fluorescent intensity of 
the composed reagent from AlamarBlue reagent and SH-SY5Y cells was read on the 
plate reader (BMG - POLARstar Omega) 2 hours after adding the cell viability reagent 
to the cells.  
Free radical scavenging test of Y2O3 NPs 
An AlamarBlue assay (ThermoFisher, DAL1100) was carried out to see whether Y2O3 
NPs would work as a free radical scavenger; in this experiment, hydrogen peroxide was 
used to induce oxidative stress.  The three aforementioned concentrations of Y2O3 NPs 
and H2O2 were evaluated together, but each concentration of Yttrium oxide NPs was 
assessed by treating it separately with three separate concentrations of hydrogen 
peroxide. The SH-SY5Y neuroblastoma human cells were subcultured in 96 – well/ flat 
– bottomed (FB) microplates (Interpath Services, 655180X) using DMEM / F12, 1 % 
PS, and 10 % FBS. On the first day of plating the cells, a concentration of 12000 / well 
cells were seeded in the plates, and on the second day the cells were treated with the 
three different concentrations of Yttrium oxide NPs mentioned above. Each 
concentration of NPs was treated 1 hour later with the three concentrations of hydrogen 
peroxide mentioned above. The PBS used a control (1:1000 medium), and AlamarBlue 
reagent (1:100 PBS) was added 48 hours later. Free radical scavenging test has assessed 
by the same process of testing the cytotoxicity of Yttrium oxide NPs. The fluorescent 
intensity of the reagent composed from AlamarBlue reagent and SH-SY5Y cells, was 
read on the plate reader (BMG - POLARstar Omega) 2 hours after adding the cell 
viability reagent to the cells.  
TEM images of the homemade and commercial MNPs 
TEM images of the homemade Y2O3 NPs were taken by NCHP team member Dean 
Cardillo in the Innovation Campus of University of Wollongong. 
Statistics 
The data for H2O2 and Y2O3 NPs are given as the mean ± standard error of the mean 
(SEM) from at least 4 independent replicates. Statistical differences were identified after 
confirming the normal distribution by one repeated measures using ANOVA with a 
Tukey post hoc comparison, as appropriate, in Graph Pad Prism software.  
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3. Results  
The impact of antioxidant NPs on SH-SY5Y viability 
Because dispersing iron oxide NPs had some issues, they were difficult to work with in 
the aqueous solutions required for cell culture. Due to their aggregation, the NPs 
remained in the culture medium and were not internalised into the cells (data not 
shown). Therefore, Yttrium oxide NPs (Y2O3 NPs) was used to test the impact that this 
type of uncoated NP would have on cell viability.  To assess whether Y2O3 NPs could 
protect against oxidative stress, different concentrations of uncoated Y2O3 NPs and 
H2O2 were tested on cell viability.  Many different concentrations of Y2O3 NPs were 
optimised before the three different concentrations mentioned below were used to treat 
the neuron cells (data not shown). Moreover, many different concentrations of H2O2 
were also optimised before the three concentrations of hydrogen peroxide mentioned 
below were chosen to continue with this research (data not shown). 
TEM images of homemade Yttrium oxide Y2O3 NPs:  
The homemade Y2O3 NPs with sizes in the range of 80 – 120 nm were synthesised by 
team member Dean Cardillo in the Innovation campus of University of Wollongong, 
Institute for Superconducting and Electronic Materials (data not shown). 
Cytotoxicity of Y2O3 NPs 
There was no real difference between the concentrations of Yttrium oxide NPs (5, 15, 
and 25 µg/ml) compared to control, thus showing that Y2O3 NPs have no negative 
impact on cell viability (overall repeated measures one – way ANOVA findings F (3, 9) = 
3.318, p = 0.1514, Figure A.1). We then moved to assess whether the NPs could protect 




Figure A.1: The cytotoxicity of Y2O3 NPs on cell viability. An AlamarBlue assay was carried 
out to illustrate the toxic impact of Yttrium oxide NPs on cell viability; there was no real 
difference between the findings compared to the control (C).  
Cytotoxicity of H2O2  
The AlamarBlue assay carried out to check the cytotoxicity of hydrogen peroxide 
indicated that 0.025, 0.05, and 0.075 mM of hydrogen peroxide had negative effects on 
cell viability (overall repeated measures one – way ANOVA findings F (3, 9) = 8.231, p = 
0. 0179, Figure A.2).  A post hoc analysis identified large reductions in cell viability for 
a range of hydrogen peroxide concentrations (p < 0.05 for 0.025 and 0.05 mM, and p < 
0.01 for 0.075 mM, Figure A.2). 
 
Figure A.2: The cytotoxicity of H2O2 on cell viability. There were large differences between all 
the results of different concentrations of hydrogen peroxide compared to the control (C). 
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Free radical scavenging test of Y2O3 NPs  
To test the anti-oxidant impact of the three different concentrations of Yttrium oxide 
NPs, H2O2 was used to induce oxidative stress within the cell culture. Each 
concentration of Yttrium oxide NPs was treated separately with three different 
concentrations of hydrogen peroxide (Figure A.3). Interestingly, the only real 
differences were between the results of (5 µg/ml of Yttrium oxide NPs + 0.025 mM of 
H2O2) compared to the same concentration of hydrogen peroxide (0.025 mM) alone 
(overall repeated measures one – way ANOVA findings F (3, 12) = 10.74, p = 0.0379, 
Figure A.3 A). A post hoc analysis identified a large increase in cell viability for (p < 
0.01 for 5 µg / ml + 0.025 mM), but no real change in cell viability for (15 µg / ml + 
0.025 mM, and 25 µg / ml + 0.025 mM) compared to 0.025 only (Figure A.3 A). 
However, when the dose of H2O2 was increased to 0.05 mM, both 5 µg / ml + 0.05 mM, 
whereas 15 µg / ml + 0.05 mM compared to 0.05 mM caused a large reduction in cell 
viability (overall repeated measures one – way ANOVA findings F (3, 12) = 7.854, p = 
0.0307, Figure A.3 B). A post hoc analysis revealed a large decrease in cell viability (p 
< 0.05 for 5 µg / ml + 0.05 mM, and p < 0.01 for 15 µg / ml + 0.05 mM, Figure A.3 B). 
Nevertheless, 25 µg / ml + 0.05 mM, and 0.05 mM did not change cell viability 
compared to the control (Figure A.3 B). Furthermore, when the dose of hydrogen 
peroxide was increased to 0.075 mM, the cell viability of all the different samples 
treated with NPs and H2O2 compared to control, had decreased significantly (overall 
repeated measures one – way ANOVA findings F (3, 12) = 11.05, p = 0.0207, Figure A.3 
C). A post hoc analysis identified a large decrease in cell viability (p < 0.01 for 5 µg / 
ml + 0.075 mM, p < 0.05 for 15 µg / ml + 0.075 mM, and 25 µg / ml + 0.075 mM, 
Figure A.3 C), which indicates that the NPs were only able to protect against hydrogen 




Figure A.3: The anti-oxidant impact of three different concentrations (5, 15, and 25 µg / ml) of 
Y2O3 NPs for the oxidative stress induced by three different concentrations (0.025, 0.05, and 
0.075 mM) of H2O2. (A) Indicates the effect of NPs concentrations on 0.025 mM. (B) Illustrates 
the influence of NPs concentrations on 0.05 mM. (C) Shows the impact of NPs concentrations 
on the 0.075 mM.  
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4. Discussion  
The ability to reduce the oxidative stress of Yttrium oxide NPs (Y2O3 NPs) induced by 
H2O2, was tested by checking the viability of SH-SY5Y cells treated with different 
concentrations of hydrogen peroxide.  
The findings suggested that 5 µg/ml of NPs only worked as free radical scavengers to 
reduce the oxidative stress induced by 0.025 mM. It did not work with higher 
concentrations of hydrogen peroxide possibly due to the increase of hydrogen peroxide 
cytotoxicity after increasing its concentration. The aggregation and sedimentation of 
NPs reduced the active surface area of NPs which work as free radical scavengers, 
thereby increasing their cytotoxicity.  Since Yttrium oxide is not coated, the aggregation 
and sedimentation of NPs occurred increased while running the experiment as the 
concentration of NPs increased; this in turn led to more cytotoxicity than with a lower 
concentration. Other concentrations of Y2O3 NPs (15 and 25 µg/ml) did not reduce the 
oxidative stress. The reasons why 15 and 25 µg/ml would not work as free radical 
scavengers might be related to the contribution of cytotoxicity between the high 
concentrations of Yttrium oxide NPs and hydrogen peroxide, or to the aggregation and 
sedimentation of high concentrations of NPs.  
Yttrium oxide NPs can work as free radical scavengers to reduce the oxidative stress 
induced by hydrogen peroxide; this feature could help to cure neurodegenerative 
diseases such as Alzheimer and Dementia, which are results of mitochondrial oxidative 
stress. Mitochondrial dysfunction is a result of an abnormal generation of reactive 
oxygen species (ROS) that could result in neuron death (Querfurth  and LaFerla 2010, 
Huang and Mucke, 2012, Tu et al., 2014, Kamenetz et al., 2003). The oxidative 
phosphorylation process which occurs inside the mitochondria provides cells with 
adenosine triphosphate (ATP) to keep cellular energy homeostasis, and the by-products 
of reactive oxygen species (ROS) produced during this procedure can lead to 
mitochondrial dysfunctions (Federico et al., 2012, Yun and Finkel, 2014, Lin and Beal, 
2006).  
There is some evidence that the toxicity of nanoparticles is due to the generation of 
reactive oxygen species (ROS) (Buzea et al., 2007), so studies are being carried out to 
examine the causes of these toxicities. The results so far indicate that the interaction of 
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metal oxide nanoparticles cells has caused DNA damage of all sorts i.e. chromosomal 
aberrations, DNA strand breakage, oxidative DNA damage and mutations (Koedrith et 
al., 2014). Therefore, the difference between MNPs and antioxidant NPs is that 
antioxidant NPs can reduce oxidative stress while MNPs can generate it. 
5. Future direction of the research  
Further research should also be undertaken to examine the cellular up-take of Y2O3 NPs 
or the internalisation of these NPs by using flow cytometry and confocal microscopy 
methods to determine where the NPs are located because it could help to declare 
whether the anti-oxidation feature of NPs occurred within the medium or inside the 
cells. Moreover, knowing their locations can help us understand the cytotoxicity and 
mechanism of the toxic effects of Y2O3 NPs.  
In this study we have found that the Y2O3 NPs can reduce the oxidative stress induced 
by small concentrations of H2O2. Also, we have found that coated Fe3O4 NPs did not 
significantly reduced cell viability. Therefore, coated MNPs combined with Y2O3 NPs 
are the best option for future research. 
Therefore, a combination of Y2O3 NPs and Fe3O4 NPs guided by EMF (AC or DC MF) 
should be considered in future research because these features can be used to cure 
neurodegenerative diseases by increasing cell viability, enhancing neurite outgrowth, 
and reducing oxidative stress.  Future research should also exploit all these materials by 
functionalising coated Fe3O4 NPs with Y2O3 NPs. The idea is to make coated Fe3O4 
NPs the core and Y2O3 NPs a shell (Y2O3 @ Fe3O4 NPs) that is guided by an external 
magnetic field. In this case we hypothesise that neuron cells can be induced 
magnetically, mechanically, and chemically, all at the same time.  
The shell Y2O3 NPs can induce the neuron cells chemically, and Y2O3 NPs can reduce 
oxidative stress by reducing the extreme ROS level inside the neuron cells.  
However, the concentrations of (Y2O3 @ Fe3O4 NPs) should first be optimised, while 
the cellular uptake of Y2O3 @ Fe3O4 NPs should be studied using confocal microscopy 
or the flow cytometry technique to determine the location of the NPs.  
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Even though Y2O3 NPs can reduce the oxidative stress of SH-SY5Y cells by small 
concentrations of H2O2, we hypothesise that Y2O3 NPs might reduce the oxidative stress 
induced by high concentrations of hydrogen peroxide if primary neuron cells are used 
rather than neuroblastoma cells. For these reasons, primary neuron cells should be 
considered in these kinds of experiments.   
6. Conclusion 
The outcomes of this preliminary study have indicated the impact of antioxidants NPs 
on SH-SY5Y neuroblastoma cells. This study showed that Y2O3 NPs can protect 
neuronal cells against oxidative stress induced by H2O2 causing mitochondrial 
dysfunction. We found that Yttrium oxide NPs could work as free radical scavengers to 
reduce the oxidative stress induced by hydrogen peroxide in SH-SY5Y cells culture.  
 
 
 
 
  
 
 
